91˿Ƶ

New Program Launch: MI4 funding for COVID-19 research

Published: 23 March 2020

The 91˿Ƶ Interdisciplinary Initiative in Infection and Immunity (MI4) is pleased to announce the launch of an emergency coronavirus research fund to support nimble and effective interventions and...

Diamond Therapeutics Signs Agreement with 91˿Ƶ for Research on Low-Dose LSD

Published: 4 February 2021

TORONTO, Feb. 4, 2021 /CNW/ - Diamond Therapeutics Inc. ("Diamond"), a leading psychedelic drug development company focused on low-dose therapies for mental health, has entered into an agreement...

R+I Services during 91˿Ƶ COVID-19 Closure

Published: 17 March 2020

Sent on behalf of Martha Crago, Vice-Principal (Research and Innovation)...

Pages

Back to top